Association Between Apolipoprotein Eϵ4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether the apolipoprotein E epsilon4 allele (apoE epsilon4) is associated with cognitive decline in individuals with and without dementia, we conducted a 4-year longitudinal study of subjects with a range of cognitive function. SETTING: At baseline, respondents (n=511) were randomly selected according to age and Mini-Mental State Examination score from a community-based study of dementia among noninstitutionalized persons aged 65 to 84 years. Respondents were examined at baseline and followed up in 3 annual visits. At baseline, subjects were classified as having normal cognitive function, minimal dementia, or dementia, according to criteria from the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) and the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Of the 511 respondents at baseline, 405 who were examined at least 2 times are included in this analysis. MAIN OUTCOME MEASURES: Cognitive decline was determined by a slope estimating yearly change in score on the neuropsychological test, the CAMCOG (the cognitive section of the CAMDEX), and its sub-scales of memory and nonmemory functions. RESULTS: Among the subjects who had normal cognitive function at baseline, apoE epsilon4 carriers showed a significantly greater decline (P<.001) in score on the CAMCOG compared with noncarriers. Differences in decline on the memory and nonmemory subtests were also significant (P<.001). Rates of cognitive decline were not related to apoE epsilon4 status in the groups with minimal dementia and dementia. CONCLUSIONS: In our community-based sample, apoE epsilon4 was associated with the rate of cognitive decline prior to the clinically symptomatic phase of dementia. Knowing the apoE epsilon4 status of those already symptomatic for dementia may not improve knowledge about a patient's prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707
Seshadri, S. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540350068018 · Cited by 163
Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Groβ, W., & März, W. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00596-w · Cited by 157
Clinical application of apolipoprotein E genotyping to Alzheimer's disease
Roses, A., Strittmatter, W., Pericak-Vance, M., Corder, E., Saunders, A., & Schmechel, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92960-2 · Cited by 125
ApoE epsilon 4 allele and cognitive decline in patients with Alzheimer's disease
Asada, T., Kariya, T., Yamagata, Z., Kinoshita, T., & Asaka, A. (1996) · Neurology · doi:10.1212/wnl.47.2.603 · Cited by 27
Cited by
Geerlings, M. I., Jonker, C., Bouter, L. M., Adèr, H. J., & Schmand, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.531 · Cited by 487
Self-citationAnstey, K., & Christensen, H. (2000) · Gerontology · doi:10.1159/000022153 · Cited by 377
“…decline; significant tests were greater on two of the tests: face and word recognition Excluded people with dementia at baseline and follow-up; no e2 data Jonker et al., 1998 [57] 405 65–84 3 Amsterdam study of the elderly from medical practice lists CAMCOG, total score, memory,…”
BackgroundGeerlings, M. I., Bouter, L. M., Schoevers, R. A., Beekman, A. T. F., Jonker, C., Deeg, D. J. H., Van Tilburg, W., Adèr, H. J., & Schmand, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.6.568 · Cited by 352
Self-citationA systematic review of cognitive decline in the general elderly population
Park, H. L., O'Connell, J. E., & Thomson, R. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1023 · Cited by 279
“Some carried out annual tests for several years (Jonker et al., 1998; Wilson et al., 1999), whilst for other studies the gap between evaluations was a long as a decade (Mortensen et al., 1993; Laursen, 1997; Lyketsos et al., 1999).”
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
TWAMLEY, E. W., ROPACKI, S. A. L., & BONDI, M. W. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060863 · Cited by 273
Metadata
- Authors
- Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1998-08-01
- Volume
- 55
- Issue
- 8
- Pages
- 1065
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2020411164
- Cited by
- 141
- References
- 7
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association Between Apolipoprotein Eϵ4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia. https://app.cochat.ai/papers/10.1001/archneur.55.8.1065
- The paper
- Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J. (1998). Association Between Apolipoprotein Eϵ4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia. Archives of Neurology. https://doi.org/10.1001/archneur.55.8.1065
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.